- Home
- Publications
- Publication Search
- Publication Details
Title
Myeloid neoplasms after chemotherapy and PRRT: myth and reality
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 23, Issue 8, Pages C1-C7
Publisher
Bioscientifica
Online
2016-06-30
DOI
10.1530/erc-16-0258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High risk of myelodysplastic syndrome and acute myeloid leukemia after177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy
- (2016) Bertrand Brieau et al. ENDOCRINE-RELATED CANCER
- Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
- (2016) Dik J. Kwekkeboom et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
- (2016) Lisa Bodei et al. SEMINARS IN NUCLEAR MEDICINE
- Therapy-Related Myeloid Neoplasms
- (2015) Carlos E. Bueso-Ramos et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Myelodysplastic syndromes in Chernobyl clean-up workers
- (2015) Daniil F. Gluzman et al. ANNALS OF HEMATOLOGY
- Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma – A systematic review
- (2015) S.C. Clement et al. CANCER TREATMENT REVIEWS
- 6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial
- (2015) J. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- Therapy-related myelodysplastic syndrome
- (2015) Myrna Candelaria et al. Expert Opinion On Drug Safety
- Analysis of 177Lu-DOTA-Octreotate Therapy-Induced DNA Damage in Peripheral Blood Lymphocytes of Patients with Neuroendocrine Tumors
- (2015) D. Denoyer et al. JOURNAL OF NUCLEAR MEDICINE
- Radiotherapy- and Chemotherapy-Induced Myelodysplasia Syndrome
- (2015) Li-Min Sun et al. MEDICINE
- Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
- (2014) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide receptor therapies in neuroendocrine tumors
- (2014) L. Bodei et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Radiation Alone for Solid Tumors and the Questionable Development of Therapy-Related Myelodysplastic Syndromes
- (2014) C. R. Cogle JNCI-Journal of the National Cancer Institute
- Recommendations for management of patients with neuroendocrine liver metastases
- (2014) Andrea Frilling et al. LANCET ONCOLOGY
- The molecular basis of myeloid malignancies
- (2014) Toshio KITAMURA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- The evolving challenge of therapy-related myeloid neoplasms
- (2013) Jane E. Churpek et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
- (2013) L. M. Morton et al. BLOOD
- Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
- (2013) Michael S. Hofman et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2013) A. Sabet et al. JOURNAL OF NUCLEAR MEDICINE
- Acute leukemia arising after radioiodine treatment for thyroid cancer
- (2012) M. Gilabert et al. HAEMATOLOGICA
- Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms
- (2012) Valentina Nardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- Therapy-related myeloid neoplasms following treatment with radioiodine
- (2011) T. Schroeder et al. HAEMATOLOGICA
- Familial myelodysplastic syndromes: a review of the literature
- (2011) E. Liew et al. HAEMATOLOGICA
- Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
- (2011) Amy Berrington de Gonzalez et al. LANCET ONCOLOGY
- 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy
- (2010) Michael Garkavij et al. CANCER
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- (2010) Michael Lassmann et al. ENDOCRINE-RELATED CANCER
- 177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide
- (2010) Daniel Hubble et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Risk of Myelodysplastic Syndromes in People Exposed to Ionizing Radiation: A Retrospective Cohort Study of Nagasaki Atomic Bomb Survivors
- (2010) Masako Iwanaga et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
- (2009) S Boehrer et al. ONCOGENE
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours
- (2008) Martijn van Essen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-Related Myeloid Leukemia
- (2008) Lucy A. Godley et al. SEMINARS IN ONCOLOGY
- The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer
- (2007) Aaron. P. Brown et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search